Original Articles

How Much Digital Rectal Examination is Valuable for the Decision of Biopsy in Patients with PSA ≤4 ng/ml?

• Özgü Aydoğdu
• İbrahim Halil Bozkurt
• Tarık Yonguç
• Tansu Değirmenci
• Salih Polat
• Bülent Günlüsoy
• İbrahim Küçüktürkmen
• Yasin Ceylan
• Süleyman Minareci

Is Prostate Specific Antigen Density more Important than in the Diagnosis of Prostate Cancer in Patients with a Total Prostate Specific Antigen Value <10 ng/mL?

• Soner Çoban
• Muhammet Güzelsoy
• Ali Rıza Türkoğlu
• Ünal Kurtoğlu
• Dursun Ünal
• Noyan Can Akdur
• Sedat Öner
• Murat Demirbaş

Review

PSA: past, today and tomorrow

• Levent Mert Günay
• Sertaç Yazıcı
• Haluk Özen

• Çagatay Gögüs

• Sinan Sözen
• Serhat Gürocak
• Cenk Acar

Yükselen PSA durumunda kullanılan görüntüleme yöntemleri bize ne ölçüde yardımcı oluyor?

• Reşit Tokuç
• Asıf Yıldırım

Tekrarlayan prostat biyopsilerinde ideal bir biyopsi şeması var mıdır? PCA3 PSA kadar faydalı mıdır?

• Kaya Horasanlı
• Mustafa Aydın

Algorithmic approach to rising PSA after curative prostate cancer treatment

• Levent Mert Günay
• Şevket Tolga Tombul
• Bülent Akdoğan

What is the best cutoff value of PSA in detection of prostate cancer

• Hakan Gemalmaz

NON-PSA biomarkers for prostate cancer

• Yarkın Kamil Yakupoğlu
• Yakup Bostancı
• Ender Özden

Evaluation of the Current Situation Tissue and Serum Biomarkers in Prostate Cancer

• Enis Kervancıoğlu
• Murat Koşan

Repeat prostate biopsy: who, when, how?

• Hayrettin Şahin

How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?

• İlker Çelen
• Murat Lekili

Rising Psa After Radical Prostatectomy: Radiotherapy in High Risk Group: Early? Late?

• Gül Alço
• Sefik İğdem

Article - Comment

• Emre Tüzel

• Bülent Akduman

Time to prostate spesific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality

• Mustafa Kaplan

Original Article

Correlation Between PSA Density and Multiparametric Prostate MRI in the Diagnosis of Prostate Cancer

• Ahmet Aslanoğlu
• Hüseyin Saygın
• Abuzer Öztürk
• İsmail Emre Ergin
• Aydemir Asdemir
• Arslan Fatih Velibeyoğlu
• Esat Korgalı

Relationship Between AMACR Staining Density of Radical Prostatectomy Specimen and Biochemical Recurrence in Patients with Pathological Stage T2a-b

• Murat Kars
• Ersin Gökmen
• Oktay Özman
• Serkan Gönültaş
• Burak Arslan

Relationship Between Biopsy Core α-Methylacyl-CoA Racemase Positivity and Five-Year Biochemical Recurrence in D’Amico Low- and Intermediate-Risk Prostate Cancer

• Ersin Gökmen
• Oktay Özman
• Murat Kars
• Serkan Gönültaş
• Burak Arslan

Determination of the PSA Cut-off Value to Predict the Clinically Significant Prostate Cancer in Patients with Positive Multiparametric MRI: A Population-based Study

• Fuat Kızılay
• Serdar Çelik
• Fehmi Narter
• Sinan Sözen
• Haluk Özen
• Bülent Akdoğan
• Güven Aslan
• Levent Türkeri
• Volkan İzol
• Bahadır Şahin
• Saadettin Eskiçorapçı
• Members of Turkish Urooncology Association

The Effects of Metabolic Syndrome on the Prediction of Prostate Cancer in Patients with a PSA Value of 2.5-4 ng/mL

• Mehmet Erhan Aydın
• Deniz Bolat
• Zafer Kozacıoğlu
• Özgür Deyirmenci

What is the Prostate Specific Antigen Cut-off Value to Detect Metastases in Ga-68 Prostate Specific Membrane Antigen Ligand Positron Emission Tomography/ Computer Tomography Imaging for Intermediate and High-risk Prostate Cancer?

• Burak Köprü
• Turgay Ebiloğlu
• Engin Kaya
• Engin Alagöz
• Murat Zor
• Mustafa Özdeş Emer
• Mesut Gürdal
• Selahattin Bedir
• Nuri Arslan

How Does Antibiotherapy Affect the Clinical Outcomes of the Patients with High Prostate Specific Antigen? An Observational Study

• Oktay Özman
• Zübeyr Talat

Comparative Usefulness of High-frequency Doppler Ultrasonography, Serum PSA Density, and Free to Total Serum PSA Ratio in the Prediction of Prostate Cancer

• Murat Tuğrul Eren
• Numan Doğu Güner

The Predictive Ability of Prostate-Specific Antigen (PSA) Density and Free/Total PSA Ratio in Diagnosing Clinically Significant Prostate Cancer (PCa) in Patients with Histologically Confirmed PCa with a PSA Level of 2.5-10 Ng/ML

• Fatih Bıçaklıoğlu
• Hasan Rıza Aydın
• Ahmet Özgür Güçtaş
• Hamit Zafer Aksoy